John Taylor

Chief Executive Officer / Board Member

John is the Co-Founder, President and CEO of Aceragen as well as a member of the Board of Directors. Prior to Aceragen, John co-founded and was President and CEO of Spyryx Biosciences to develop inhaled peptides for cystic fibrosis.

Previously, John held the position of Vice President of Corporate Development with Synageva BioPharma, where he was crucial to taking the biotechnology company public. Prior to that, he was the Vice President of Business Development for Javelin Pharmaceuticals and a senior business development leader with Eurand Pharmaceuticals.

John received his bachelor’s degree in biological sciences from Clemson University and his master’s degree in technology management from the Wharton School of Business at the University of Pennsylvania.